Search Results - "SCHOTT, Herbert"

Refine Results
  1. 1

    Liposome Formulations of Hydrophobic Drugs by Schwendener, Reto A, Schott, Herbert

    “…Here we report methods of preparation for liposome formulations containing lipophilic drugs. In contrast to the encapsulation of water soluble compounds into…”
    Get more information
    Journal Article
  2. 2

    Heterodinucleoside Phosphates of 5-Fluorodeoxyuridine and Arabinofuranosylcytosine - New Drugs in Cancer Chemotherapy? by Saiko, Philipp, Horvath, Zsuzsanna, Jaeger, Walter, Schott, Herbert, Fritzer-Szekeres, Monika, Szekeres, Thomas

    Published in In vivo (Athens) (01-01-2005)
    “…The incidence of cancer is rapidly increasing and malignancies have become the number two cause of deaths in the Western world after cardiovascular diseases…”
    Get full text
    Journal Article
  3. 3

    N 4-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine—New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate) by Schott, Herbert, Goltz, Daniel, Schott, Timm C., Jauch, Claudia, Schwendener, Reto A.

    Published in Bioorganic & medicinal chemistry (01-06-2011)
    “…New cytostatic antimetabolite-bisphosphonates. Amino-bisphosphonates (alendronate, pamidronate) were covalently linked in a three step synthesis, with…”
    Get full text
    Journal Article
  4. 4

    Synthesis and in vitro activities of new anticancer duplex drugs linking 2′-deoxy-5-fluorouridine (5-FdU) with 3′- C-ethynylcytidine (ECyd) via a phosphodiester bonding by Schott, Herbert, Schott, Sarah, Schwendener, Reto A.

    Published in Bioorganic & medicinal chemistry (01-10-2009)
    “…Antitumor active duplex drugs linking 2′-deoxy-5-fluorouridine with 3′- C-ethynylcytidine via a 5′→5′ (A) or a 3′→5′ (B) phosphodiester bonding. Two isomeric…”
    Get full text
    Journal Article
  5. 5

    Liposome formulations of hydrophobic drugs by Schwendener, Reto A, Schott, Herbert

    “…Here, we report methods of preparation for liposome formulations containing lipophilic drugs. In contrast to the encapsulation of water-soluble compounds into…”
    Get more information
    Journal Article
  6. 6

    Cytostatic Activity of a 5-Fluoro-2'-deoxyuridine―Alendronate Conjugate against Gastric Adenocarcinoma and Non-malignant Intestinal and Fibroblast Cell Lines by WEINREICH, Jurgen, SCHOTT, Timm C, KÖNIGSRAINER, Ingmar, KÜPER, Markus, KÖNIGSRAINER, Alfred, SCHOTT, Herbert

    Published in Anticancer research (01-10-2012)
    “…5-Fluoro-2'-deoxyuridine (5-FdU), a drug against gastric cancer, was covalently linked via its nucleobase with the amino-bisphosphonate alendronate (Ale),…”
    Get full text
    Journal Article
  7. 7

    Cytostatic activity of the duplex drug linking 2′-deoxy-5-fluorouridine (5FdU) with 3′-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines by Weinreich, Jürgen, Schott, Sarah, Königsrainer, Ingmar, Zieker, Derek, Königsrainer, Alfred, Schott, Herbert

    Published in Investigational new drugs (01-12-2011)
    “…Summary The cytostatic potential of the new duplex drug 2′-deoxy-5-fluorouridylyl-(5′➔5′)-3′-C-ethynylcytidine (5FdU(5′-5′)ECyd) was evaluated in comparison to…”
    Get full text
    Journal Article
  8. 8

    N super(4)-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine - New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate) by Schott, Herbert, Goltz, Daniel, Schott, Timm C, Jauch, Claudia, Schwendener, Reto A

    Published in Bioorganic & medicinal chemistry (01-06-2011)
    “…Amino-bisphosphonates (alendronate, pamidronate) were covalently linked in a three step synthesis, with protected and triazolylated derivatives of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy by Marty, Cornelia, Langer-Machova, Zuzana, Sigrist, Sandra, Schott, Herbert, Schwendener, Reto A., Ballmer-Hofer, Kurt

    Published in Cancer letters (28-04-2006)
    “…Tumor endothelial marker 1 (TEM1) is a protein predominantly expressed on the cell surface of endothelial cells in newly developing blood vessels and on tumor…”
    Get full text
    Journal Article
  11. 11

    N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine—New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate) by Schott, Herbert, Goltz, Daniel, Schott, Timm C, Jauch, Claudia, Schwendener, Reto A

    Published in Bioorganic & medicinal chemistry (01-06-2011)
    “…Amino-bisphosphonates (alendronate, pamidronate) were covalently linked in a three step synthesis, with protected and triazolylated derivatives of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue by Schott, Herbert, Hamprecht, Klaus, Schott, Sarah, Schott, Timm C., Schwendener, Reto A.

    Published in Bioorganic & medicinal chemistry (2009)
    “…To prepare a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via a lipophilic octadecylglycerol residue we condensed 1-…”
    Get full text
    Journal Article
  14. 14

    Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine by Bijnsdorp, Irene V, Schwendener, Reto A, Schott, Herbert, Fichtner, Iduna, Smid, Kees, Laan, Adrie C, Schott, Sarah, Losekoot, Nienke, Honeywell, Richard J, Peters, Godefridus J

    Published in Investigational new drugs (01-04-2011)
    “…Prodrugs can have the advantage over parent drugs in increased activation and cellular uptake. The multidrug ETC-L-FdUrd and the duplex drug ETC-FdUrd are…”
    Get full text
    Journal Article
  15. 15

    Cellular pharmacology of multi- and duplex drugsconsisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine by Bijnsdorp, Irene V., Schwendener, Reto A., Schott, Herbert, Fichtner, Iduna, Smid, Kees, Laan, Adrie C., Schott, Sarah, Losekoot, Nienke, Honeywell, Richard J., Peters, Godefridus J.

    Published in Investigational new drugs (01-04-2011)
    “…Summary Prodrugs can have the advantage over parent drugs in increased activation and cellular uptake. The multidrug ETC-L-FdUrd and the duplex drug ETC-FdUrd…”
    Get full text
    Journal Article
  16. 16

    Synthesis and anticancer activities of amphiphilic 5-fluoro-2′-deoxyuridylic acid prodrugs by Ludwig, Peter S., Schwendener, Reto A., Schott, Herbert

    Published in European journal of medicinal chemistry (01-05-2005)
    “…Amphiphilic anticancer prodrugs of 5′-fluoro-2′-deoxyuridine-5′-monophosphate (5-FdUMP) were synthesized according to the hydrogen phosphonate method by…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Separation and sequencing of the sequence isomers of pyrimidine deoxypentanucleoside tetraphosphates by high-performance liquid chromatography by Dizdaroglu, M, Simic, M G, Schott, H

    Published in Journal of chromatography (01-01-1980)
    “…Chemical synthesis of DNA fragments with a defined sequence is extremely long and complex. A simpler alternative is isolation of fragments from partially…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Lipophilic arabinofuranosyl cytosine derivatives in liposomes by Schwendener, Reto, Schott, Herbert

    Published in Methods in enzymology (2005)
    “…Highly lipophilic drugs can be used therapeutically only by the addition of possibly toxic solubilizing agents or by development of complex pharmaceutical…”
    Get more information
    Journal Article